Dr. Martine F. Roussel is a pioneer in the field of molecular oncology and translation cancer research, having discovered some of the earliest recognized retroviral oncogenes and defined central elements in cell cycle regulation. Born and educated in France, with research experiences spanning the globe, Dr. Roussel carved an impressive path that has shattered glass ceilings and earned renowned honors. Elected to the American Academy of Arts and Sciences in 2011, National Academy of Science in 2019 and a Fellow of the AACR in 2021, Dr. Roussel continues her long-standing and illustrious career at St. Jude driving discovery, creating clinical impact, and inspiring the next generation of scientists. Dr. Roussel is a transformative force in the pediatric brain tumor community thanks not only to her robust research portfolio, but her commitment to mentorship and training.
Dr. Charles J. Sherr has made seminal contributions to the understanding of oncogenes and tumor suppressors, the mechanics of cell division cycle control, and how key cell cycle regulators are perturbed in cancer. His accomplishments have justly earned his election to the AAAS, to the National Academies of Science and Medicine, and as an Inaugural Fellow of AACR, among notable other awards and appointments. Dr. Sherr was the recipient of continuous, unfettered support from the Howard Hughes Medical Institute for 30 years until he transitioned to emeritus status in 2019. In partnership with longtime collaborator and spouse, Dr. Martine Roussel, Dr. Sherr transformed the basic and translational pediatric cancer research landscape of St. Jude.